drugset / Trial / NCT02348203

Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

NCT02348203

Phase 2 Completed 63 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupSingle-blindPrevention

Summary

This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers.

Timeline

Start
2016-01-13
Primary completion
2019-02-22
Completion
2021-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule Oral
Subject Zileuton Small molecule Oral

Indications